Abstract
Our objective was to evaluate the association between switching from warfarin to non-vitamin K oral anticoagulants (NOACs) and potential drug-drug interactions (DDIs), healthcare utilization, and expenditures in working-age adults with atrial fibrillation (AF). We conducted a retrospective cohort study using data from 2010 to 2015 for patients who switched from warfarin to NOACs (switchers) and those who continued to receive warfarin (non-switchers). We identified medications known or suspected to have clinically significant interactions with NOACs or warfarin. We used multivariate logistic regression, negative binomial, and generalized linear models to evaluate the influence of switching to NOACs and of potential DDIs on inpatient visits, outpatient visits, number of outpatient visits, and non-drug medical expenditures. Inverse probability of treatment weighting was also applied in analyses. A total of 4126 patients with AF were included in the study. Switching to NOACs was significantly and negatively related to the number of outpatient, inpatient, and emergency room (ER) visits and non-drug medical expenditures. When potential DDIs were included in the models, switching remained significantly associated only with reduced inp...Continue Reading
References
Mar 30, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Bernd BrüggenjürgenStefan N Willich
May 1, 2010·Thrombosis and Haemostasis·Paul S GarcíaJerrold H Levy
Mar 2, 2011·Journal of Thrombosis and Thrombolysis·Edith NutescuErika Hellenbart
Aug 30, 2011·The New England Journal of Medicine·Jessica L Mega
Jan 25, 2012·The American Journal of Medicine·Jacques BaillargeonYong-Fang Kuo
Oct 6, 2012·BMJ : British Medical Journal·Bruce GuthrieStewart W Mercer
Jun 26, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Doug CoyleGeorge A Wells
Apr 2, 2014·Journal of the American College of Cardiology·Craig T JanuaryClyde W Yancy
May 17, 2014·Journal of Medical Economics·T LanitisI Durand-Zaleski
Mar 13, 2015·BMJ : British Medical Journal·Siobhan DumbreckBruce Guthrie
Apr 9, 2015·Stroke; a Journal of Cerebral Circulation·Guijing WangMary G George
Sep 12, 2015·Current Medical Research and Opinion·Kevin FrancisDavid Matchar
Feb 10, 2016·Clinical Therapeutics·Tim BancroftJason P Swindle
Jun 19, 2016·The Annals of Pharmacotherapy·Nghi B HaJerod Nagel
Jun 22, 2017·The Annals of Pharmacotherapy·Xue FengUsha Sambamoorthi
Jun 24, 2017·Health and Quality of Life Outcomes·Shannon L ReynoldsGeorge Andrews
Jul 7, 2017·Population Health Management·Xue FengUsha Sambamoorthi
Aug 11, 2017·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Adrienne M GilliganDavid M Smith
Oct 31, 2017·Journal of Managed Care & Specialty Pharmacy·Steven DeitelzweigJay Lin